Does New Hampshire Medicaid cover GLP-1s for weight loss?

New Hampshire Medicaid covers Wegovy and Zepbound for heart risk, MASH or sleep apnea, not for weight loss alone

Not for weight loss alone
By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

If you are an adult and weight loss is your only reason, New Hampshire Medicaid does not cover a GLP-1.

If one of the uses below applies to you, your prescriber can ask New Hampshire Medicaid to cover that drug. Read the rule and its criteria.

  • Nofor adult weight loss alone
  • Jan 1, 2026when the rules we checked took effect
  • $49/molowest cash price in New Hampshire, at Embody

Which drugs New Hampshire Medicaid covers, and for what:

Wegovy
Heart risk, as the injection, or MASH
Zepbound
Sleep apnea

We checked 5 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in New Hampshire?

8 programs that serve New Hampshire publish a complete monthly price, from $49 at Embody to $299 at Willow.

Programs that serve New Hampshire, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

3 more programs serve New Hampshire without one complete monthly price: Collective, Maximus and Wellorithm. Compare their terms in the price index.

We left out 29 programs whose service-area list has a caveat for New Hampshire or is incomplete, so confirm your address at intake.

A program that serves New Hampshire still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in New Hampshire$49/moAt Embody, the lowest complete monthly price among programs that serve New Hampshire.
  • National median$124/moThe median advertised recurring price across 10 compounded programs we track, a national benchmark, not a measured New Hampshire average.
  • National range$49 to $299The lowest and highest advertised recurring prices in that group.

What does New Hampshire Medicaid cover for GLP-1s?

Here is our summary of the New Hampshire Medicaid rules we checked, with their criteria and limits.

New Hampshire Medicaid covers Wegovy for heart risk or MASH and Zepbound for sleep apnea, but it stopped covering GLP-1 medicines prescribed only for weight loss on January 1, 2026, under a state notice to providers dated October 9, 2025. The notice names Saxenda, Wegovy and Zepbound, and the fee-for-service drug list effective October 1, 2026 includes none of them. New Hampshire Medicaid can still approve Wegovy injection to lower your heart risk if you have established heart disease, a BMI of 27 or more, no diabetes and a documented 3-month low-calorie diet. It can also approve Wegovy for MASH with F2 or F3 liver fibrosis when a liver or digestive specialist prescribes it. It can approve Zepbound if a sleep study confirms moderate to severe obstructive sleep apnea and you have a BMI of 27 or more, no diabetes and regular PAP machine use. New Hampshire Medicaid uses separate criteria for older weight-loss pills such as phentermine and orlistat. If you are in a managed-care plan, ask your plan how it applies these rules.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked NH Medicaid provider notice, October 9, 2025: GLP-1 weight-loss coverage ends January 1, 2026 on October 15, 2026.

We checked NH Medicaid fee-for-service Wegovy cardiovascular (MACE) criteria on October 15, 2026.

We checked NH Medicaid fee-for-service Zepbound sleep apnea criteria on October 15, 2026.

We checked NH Medicaid fee-for-service MASH criteria (Rezdiffra, Wegovy) on October 15, 2026.

We checked NH Medicaid fee-for-service preferred drug list, effective October 1, 2026 on October 15, 2026.

What should you ask New Hampshire Medicaid before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends New Hampshire Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and New Hampshire Medicaid decides.

What New Hampshire Medicaid's own criteria ask for, from the documents we read:

  • For Wegovy's heart-risk route, established heart disease, a BMI of 27 or more, no diabetes and a documented 3-month low-calorie diet.
  • For Zepbound, a sleep study confirming moderate to severe obstructive sleep apnea, a BMI of 27 or more, no diabetes and regular PAP machine use.

What your prescriber usually sends:

  • The condition the request relies on, as New Hampshire Medicaid names it: Wegovy for heart risk, as the injection, or MASH; Zepbound for sleep apnea.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these New Hampshire Medicaid documents:

Your prescriber's office files the request; you cannot file it yourself. If New Hampshire Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in New Hampshire?

Medicare's GLP-1 Bridge follows federal rules in every state, so New Hampshire Medicaid's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in New Hampshire?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. New Hampshire Department of Health and Human Services
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. New Hampshire SHIP counseling

Questions about GLP-1 access in New Hampshire

Does New Hampshire Medicaid cover GLP-1 medication for weight loss?

New Hampshire Medicaid covers Wegovy for heart risk or MASH and Zepbound for sleep apnea, but it stopped covering GLP-1 medicines prescribed only for weight loss on January 1, 2026, under a state notice to providers dated October 9, 2025.

The notice names Saxenda, Wegovy and Zepbound, and the fee-for-service drug list effective October 1, 2026 includes none of them. New Hampshire Medicaid can still approve Wegovy injection to lower your heart risk if you have established heart disease, a BMI of 27 or more, no diabetes and a documented 3-month low-calorie diet. It can also approve Wegovy for MASH with F2 or F3 liver fibrosis when a liver or digestive specialist prescribes it. It can approve Zepbound if a sleep study confirms moderate to severe obstructive sleep apnea and you have a BMI of 27 or more, no diabetes and regular PAP machine use. New Hampshire Medicaid uses separate criteria for older weight-loss pills such as phentermine and orlistat. If you are in a managed-care plan, ask your plan how it applies these rules. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in New Hampshire?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not New Hampshire Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in New Hampshire?

Yes, from 11 online programs that publish a service area including New Hampshire.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in New Hampshire?

Among programs that serve New Hampshire, the lowest complete monthly price we found is $49 at Embody.

Across the 10 compounded programs we track nationally, the median advertised recurring price is $124/mo, from $49 to $299. That national figure is not a measured New Hampshire average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

Embody illustration of a compounded semaglutide injection vial
from $49/mo·Compounded

Collective

Collective provider illustration of compounded semaglutide injection vial
from $59/mo + $199/year membership after 21 days·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.